Filtered By:
Condition: Fatty Liver Disease (FLD)
This page shows you your search results in order of date.
Order by Relevance | Date
Total 312 results found since Jan 2013.
Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women
Non-alcoholic fatty liver disease (NAFLD) is a progressive metabolic disease characterized by hepatic steatosis, inflammation, and fibrosis that seriously endangers global public health. Epidemiological studies have shown that the incidence of non-alcoholic fatty liver disease in postmenopausal women has significantly increased. Studies have shown that estrogen deficiency is the main reason for this situation, and supplementing estrogen has become a new direction for preventing the occurrence of postmenopausal fatty liver. However, although classical estrogen replacement therapy can reduce the incidence of postmenopausal N...
Source: Frontiers in Pharmacology - August 30, 2023 Category: Drugs & Pharmacology Source Type: research
Therapeutics of Extracellular Vesicles in Cardiocerebrovascular and Metabolic Diseases
Adv Exp Med Biol. 2023;1418:187-205. doi: 10.1007/978-981-99-1443-2_13.ABSTRACTExtracellular vesicles (EVs) are nanoscale membranous vesicles containing DNA, RNA, lipids, and proteins, which play versatile roles in intercellular communications. EVs are increasingly being recognized as the promising therapeutic agents for many diseases, including cardiocerebrovascular and metabolic diseases, due to their ability to deliver functional and therapeutical molecules. In this chapter, the biological characteristics and functions of EVs are briefly summarized. Importantly, the current state of applying EVs in the prevention and tr...
Source: Advances in Experimental Medicine and Biology - August 21, 2023 Category: Research Authors: Zhitao Hou Yiyan Lin Xinyu Yang Jing Chen Guoping Li Source Type: research
Associations of MAFLD and MAFLD subtypes with the risk of the incident myocardial infarction and stroke
In conclusion, a diagnosis of MAFLD is associated with an increased risk of MI or stroke, and the assessment of MAFLD and its subtypes should be a component of the cardiovascular risk assessment.PMID:37586479 | DOI:10.1016/j.diabet.2023.101468
Source: Diabetes and Metabolism - August 16, 2023 Category: Endocrinology Authors: Shen Chen Hongliang Xue Rong Huang Ke Chen Haoyang Zhang Xu Chen Source Type: research
Two signs of 'severe' fatty liver disease that could be mistaken for heat stroke
It is thought that one in three people in the UK are living with very early stage fatty liver disease due to small amounts of fat in the liver.
Source: Daily Express - Health - July 26, 2023 Category: Consumer Health News Source Type: news
